Literature DB >> 1192052

Ocular reaction to propranolol and resolution on continued treatment with a different beta-blocking drug.

R B Cubey, S H Taylor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1192052      PMCID: PMC1675215          DOI: 10.1136/bmj.4.5992.327

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  2 in total

1.  Oculocutaneous reaction to oxprenolol.

Authors:  P J Holt; E Waddington
Journal:  Br Med J       Date:  1975-06-07

2.  Autoimmune haemolytic anaemia associated with alpha-methyldopa therapy.

Authors:  S M Worlledge; K C Carstairs; J V Dacie
Journal:  Lancet       Date:  1966-07-16       Impact factor: 79.321

  2 in total
  8 in total

Review 1.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

2.  Eye symptoms in patients taking propranolol and other hypotensive agents.

Authors:  C T Dollery; C J Bulpitt; J Daniel; P Clifton
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

3.  Cheilostomatitis associated with propranolol treatment.

Authors:  S E Tangarud; S Golf
Journal:  Br Med J       Date:  1977-11-26

4.  Drug-induced localized systemic scleroses.

Authors:  J R Graham
Journal:  Trans Am Clin Climatol Assoc       Date:  1981

5.  Ocular reaction to timolol maleate.

Authors:  M A Frais; T J Bayley
Journal:  Postgrad Med J       Date:  1979-12       Impact factor: 2.401

6.  Beta-adrenergic receptor blocking drugs: tear lysozyme and immunological screening for adverse reaction.

Authors:  I A Mackie; D V Seal; J M Pescod
Journal:  Br J Ophthalmol       Date:  1977-05       Impact factor: 4.638

7.  Intensive care in tetanus: management, complications, and mortality in 100 cases.

Authors:  R S Edmondson; M W Flowers
Journal:  Br Med J       Date:  1979-05-26

8.  Antihypertensive therapy with a single daily dose of acebutolol in essential hypertension, response and ophthalmological assessment in the Japanese.

Authors:  K Sekine; M Takahashi; E Ogata; T Ohnishi; M Takase
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.